Importantly, the isolated sPD-1 protein retained its ability to specifically bind PD-L1 expressed on NB tumor cell lines, as demonstrated by the abrogation of sPD-1/PD-L1 interaction upon treatment with Atezolizumab. The gene discussed is HOXD13; the disease is neoplasm.